| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | Renninger Robert CHIEF FINANCIAL OFFICER | Sale | -906 | -5.41%15,851 | $5.37 | $4,865 | View SEC filing | |
| 2026-03-05 | Worthington Mark GENERAL COUNSEL and CCO | Sale | -1,328 | -6.74%18,376 | $5.37 | $7,131 | View SEC filing | |
| 2026-03-05 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | -1,359 | -5.12%25,178 | $5.37 | $7,298 | View SEC filing | |
| 2026-03-05 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | -1,720 | -9.77%15,887 | $5.37 | $9,236 | View SEC filing | |
| 2026-03-05 | Litton Mark James PRESIDENT and CEO | Sale | -5,156 | -7.93%59,894 | $5.37 | $27,688 | View SEC filing | |
| 2026-01-05 | Renninger Robert Chief Financial Officer | Sale | -297 | -2.26%12,857 | $6.88 | $2,043 | View SEC filing | |
| 2026-01-05 | Worthington Mark General Counsel and CCO | Sale | -876 | -5.90%13,978 | $6.88 | $6,027 | View SEC filing | |
| 2026-01-05 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | -876 | -4.06%20,681 | $6.88 | $6,027 | View SEC filing | |
| 2026-01-05 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | -1,644 | -13.89%10,189 | $6.88 | $11,311 | View SEC filing | |
| 2026-01-05 | Litton Mark James President and CEO | Sale | -2,586 | -5.70%42,796 | $6.88 | $17,792 | View SEC filing | |
| 2025-07-02 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | -8,526 | -4.81%168,901 | $0.29 | $2,502 | View SEC filing | |
| 2025-07-02 | Litton Mark James President and CEO | Sale | -25,123 | -6.78%345,491 | $0.29 | $7,374 | View SEC filing | |
| 2025-07-02 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | -10,842 | -13.14%71,665 | $0.29 | $3,182 | View SEC filing | |
| 2025-07-02 | Worthington Mark General Counsel and CCO | Sale | -8,526 | -7.08%111,875 | $0.29 | $2,502 | View SEC filing | |
| 2025-07-02 | Renninger Robert SVP, Finance and Accounting | Sale | -2,897 | -2.58%109,186 | $0.29 | $850 | View SEC filing | |
| 2025-01-03 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | -10,826 | -23.20%35,841 | $0.56 | $6,083 | View SEC filing | |
| 2025-01-03 | Litton Mark James President and CEO | Sale | -25,107 | -8.74%262,280 | $0.56 | $14,108 | View SEC filing | |
| 2025-01-03 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | -8,510 | -6.11%130,761 | $0.56 | $4,782 | View SEC filing | |
| 2025-01-03 | Renninger Robert VP of Finance | Sale | -2,881 | -3.11%89,724 | $0.56 | $1,619 | View SEC filing | |
| 2025-01-03 | Worthington Mark General Counsel and CCO | Sale | -8,510 | -9.23%83,735 | $0.56 | $4,782 | View SEC filing | |
| 2024-09-05 | Gengos Andrew CFO and Chief Business Officer | Sale | -1,272 | -1.29%97,532 | $0.57 | $720 | View SEC filing | |
| 2024-09-05 | Lenington Rachel COO and CDO | Sale | -2,525 | -10.79%20,870 | $0.57 | $1,429 | View SEC filing | |
| 2024-09-05 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | -2,525 | -2.65%92,684 | $0.57 | $1,429 | View SEC filing | |
| 2024-09-05 | Worthington Mark GENERAL COUNSEL | Sale | -2,525 | -4.64%51,927 | $0.57 | $1,429 | View SEC filing | |
| 2024-09-05 | Litton Mark James President and CEO | Sale | -5,032 | -2.73%179,054 | $0.57 | $2,848 | View SEC filing |
1-25 of 56
